Coronary revascularisation provides no meaningful clinical benefit over optimal medical therapy in patients with stable ischaemic heart failure - CONTRA
26 May 2018 (15:05 - 15:15)
Organised by:
Slides
About the speaker
Yale School of Medicine, New Haven (United States of America)
15 More presentations in this session
Access the full session
The Event
Heart Failure 2018
26 May 2018
15:05 CET
